Advertisement
Screener

Adial Pharmaceuticals, Inc. (ADIL) Proceeds from Issuance of Private Placement

1.7 / 5 stars · 15/45 Roast Me

Adial Pharmaceuticals, Inc. Proceeds from Issuance of Private Placement

Adial Pharmaceuticals, Inc. (ADIL) reported Proceeds from Issuance of Private Placement of $26.80 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-14.

Financial Statements › Cash Flow › Financing Activities

us-gaap:ProceedsFromIssuanceOfPrivatePlacement · last filed 2026-08-14

  • Adial Pharmaceuticals, Inc. proceeds from issuance of private placement for the quarter ending 2023-12-31 was $0.00.
  • Adial Pharmaceuticals, Inc. proceeds from issuance of private placement for the quarter ending 2023-09-30 was $0.00.
  • Adial Pharmaceuticals, Inc. proceeds from issuance of private placement for fiscal 2023 was $58.54K.
Period endProceeds from Issuance of Private Placement 3 monthProceeds from Issuance of Private Placement 6 monthProceeds from Issuance of Private Placement 9 monthProceeds from Issuance of Private Placement 12 month
2026-06-30$26.80M
10-Q · filed 2026-08-14
2023-12-31$0.00
derived: 10-K 12 month − 10-Q 9 month · filed 2024-04-01
$0.00
derived: sum of 2 quarters · filed 2024-04-01
$58.54K
10-K · filed 2024-04-01
2023-09-30$0.00
derived: 10-Q 9 month − 10-Q/A 6 month · filed 2023-11-14
$58.54K
10-Q · filed 2023-11-14
2023-06-30$58.54K
10-Q/A · filed 2023-10-30

Similar stocks

Stock NameCountryMarket CapPE Ratio
Phio Pharmaceuticals Corp. (PHIO)United States$0.012B-0.92
Scienture Holdings, Inc. (SCNX)United States$0.012B-0.38
KIORA PHARMACEUTICALS INC (KPRX)United States$0.012B
BIOVIE INC. (BIVI)United States$0.012B
Dare Bioscience, Inc. (DARE)United States$0.011B
Aspire Biopharma Holdings, Inc. (ASBP)United States$0.012B-0.60
Tempest Therapeutics, Inc. (TPST)United States$0.013B
AEON Biopharma, Inc. (AEON)United States$0.013B-0.36
Moleculin Biotech, Inc. (MBRX)United States$0.011B
MetaVia Inc. (MTVA)United States$0.011B-0.65